These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 16757600)

  • 21. Proficiency of Italian clinical laboratories in detecting reduced glycopeptide susceptibility in Enterococcus and Staphylococcus spp. using routine laboratory methodologies.
    Jones ME; Gesu G; Ortisi G; Sahm DF; Critchley IA; Goglio A;
    Clin Microbiol Infect; 2002 Feb; 8(2):101-11. PubMed ID: 11952723
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification and susceptibility testing of Staphylococcus aureus by direct inoculation from positive BACTEC blood culture bottles.
    Diederen BM; Zieltjens M; Wetten H; Buiting AG
    Clin Microbiol Infect; 2006 Jan; 12(1):84-6. PubMed ID: 16460552
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimicrobial activity of tigecycline and comparative agents against clinical isolates of staphylococci and enterococci from ICUs and general hospital wards at three Swedish university hospitals.
    Claesson C; Nilsson LE; Kronvall G; Walder M; Sörberg M
    Scand J Infect Dis; 2009; 41(3):171-81. PubMed ID: 19173129
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical validation of the molecular BD GeneOhm StaphSR assay for direct detection of Staphylococcus aureus and methicillin-resistant Staphylococcus aureus in positive blood cultures.
    Stamper PD; Cai M; Howard T; Speser S; Carroll KC
    J Clin Microbiol; 2007 Jul; 45(7):2191-6. PubMed ID: 17522275
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of staphylococci by Phoenix: validation of a new protocol and comparison with Vitek 2.
    Chatzigeorgiou KS; Siafakas N; Petinaki E; Argyropoulou A; Tarpatzi A; Bobola M; Paniara O; Velegraki A; Zerva L
    Diagn Microbiol Infect Dis; 2010 Dec; 68(4):375-81. PubMed ID: 21094424
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of RAISUS, a novel system for identification and antimicrobial susceptibility testing for enterococci.
    Kanemitsu K; Kunishima H; Inden K; Hatta M; Saga T; Ueno K; Harigae H; Ishizawa K; Kaku M
    Diagn Microbiol Infect Dis; 2005 Sep; 53(1):23-7. PubMed ID: 15994047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification and antimicrobial susceptibility testing of clinical isolates of nonfermenting gram-negative bacteria by the Phoenix Automated Microbiology System.
    Endimiani A; Luzzaro F; Tamborini A; Lombardi G; Elia V; Belloni R; Toniolo A
    New Microbiol; 2002 Jul; 25(3):323-9. PubMed ID: 12173774
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Performance of Vitek 2 for antimicrobial susceptibility testing of Staphylococcus spp. and Enterococcus spp.
    Bobenchik AM; Hindler JA; Giltner CL; Saeki S; Humphries RM
    J Clin Microbiol; 2014 Feb; 52(2):392-7. PubMed ID: 24478467
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activity of dalbavancin tested against Staphylococcus spp. and beta-hemolytic Streptococcus spp. isolated from 52 geographically diverse medical centers in the United States.
    Biedenbach DJ; Ross JE; Fritsche TR; Sader HS; Jones RN
    J Clin Microbiol; 2007 Mar; 45(3):998-1004. PubMed ID: 17215346
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the BD Phoenix M50 Automated Microbiology System for Antimicrobial Susceptibility Testing with Clinical Isolates in Korea.
    Hong JS; Kim D; Kang DY; Park BY; Yang S; Yoon EJ; Lee H; Jeong SH
    Microb Drug Resist; 2019 Oct; 25(8):1142-1148. PubMed ID: 31161952
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extended-spectrum Beta-lactamase detection with different panels for automated susceptibility testing and with a chromogenic medium.
    Färber J; Moder KA; Layer F; Tammer I; König W; König B
    J Clin Microbiol; 2008 Nov; 46(11):3721-7. PubMed ID: 18845821
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Evaluation of the BD phoenix automated microbiology system SMIC/ID-2 panel for antimicrobial susceptibility testing of Streptococcus pneumoniae].
    Lee KK; Ryoo NH; Kim ST; Chae SL; Huh HJ
    Korean J Lab Med; 2009 Jun; 29(3):212-7. PubMed ID: 19571618
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the VITEK 2 system for identification and antimicrobial susceptibility testing of medically relevant gram-positive cocci.
    Ligozzi M; Bernini C; Bonora MG; De Fatima M; Zuliani J; Fontana R
    J Clin Microbiol; 2002 May; 40(5):1681-6. PubMed ID: 11980942
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Comparison between Phoenix system and agar-based methods for antimicrobial susceptibility testing of Streptococcus spp].
    Martínez-Lamas L; Treviño M; Romero-Jung PA; Regueiro BJ
    Rev Esp Quimioter; 2008 Sep; 21(3):184-8. PubMed ID: 18792820
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Determination of the susceptibility of staphylococci and enterococci to plycopeptides by the E-test method].
    Plotton N; Cavallo JD; Crenn Y; Meyran M
    Pathol Biol (Paris); 1994 May; 42(5):468-70. PubMed ID: 7824315
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multicentre surveillance of antimicrobial resistance in enterococci and staphylococci from Colombian hospitals, 2001-2002.
    Arias CA; Reyes J; Zúñiga M; Cortés L; Cruz C; Rico CL; Panesso D;
    J Antimicrob Chemother; 2003 Jan; 51(1):59-68. PubMed ID: 12493788
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antimicrobial susceptibility of gram-positive bacteria isolated from European medical centres: results of the Daptomycin Surveillance Programme (2002-2004).
    Sader HS; Streit JM; Fritsche TR; Jones RN
    Clin Microbiol Infect; 2006 Sep; 12(9):844-52. PubMed ID: 16882289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of daptomycin-nonsusceptible strains using the Neo-Sensitab prediffusion method.
    Katz BD; Luperchio SA; Thorne GM
    Diagn Microbiol Infect Dis; 2008 Jul; 61(3):315-20. PubMed ID: 18339508
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of two commercial susceptibility test methods for determination of daptomycin MICs.
    Jorgensen JH; Crawford SA
    J Clin Microbiol; 2006 Jun; 44(6):2126-9. PubMed ID: 16757608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the BD GeneOhm VanR assay to culture for identification of vancomycin-resistant enterococci in rectal and stool specimens.
    Stamper PD; Cai M; Lema C; Eskey K; Carroll KC
    J Clin Microbiol; 2007 Oct; 45(10):3360-5. PubMed ID: 17704282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.